ABCR  Vol.8 No.2 , April 2019
Genetic Variation of hTERT, Leukocyte Telomere Length and the Risk of Breast Cancer: A Case-Control Study in Egyptian Females
Abstract: Background: hTERT is a key player in telomere biology and its activity is directly related to cell senescence and development of many health-related problems including cancer. Although previous studies investigated this association, the results greatly vary among populations. This study aimed to investigate the association of hTERT gene SNPs and the risk of breast cancer (BC) in Egyptian females and their impact on telomere length (TL). Methods: 218 BC patients and 178 age-matched healthy females were genotyped for hTERT variants rs2736098G > A, rs2735940C > T using PCR-RFLP and for MNS16A tandem repeat using PCR to determine their association with breast cancer risk. Telomere length was measured using qPCR. Results: hTERT rs2736098G > A results indicated that both AG and GG genotypes and G allele were associated with an increased risk of BC. The rs2735940 TT genotype was significantly associated with BC risk, however, the MNS16A tandem repeat region polymorphism didn’t show any correlation with the risk of developing BC. TL showed a significant reduction in BC patients with age < 40 years compared with controls. However, it didn’t show a significant difference above the age of 40 years. Conclusions: hTERT rs2736098 and rs27365940, not MNS16A may be associated with an increased risk of developing BC in Egyptian females. Also, telomere length can be a promising screening marker of BC especially in young population.
Cite this paper: Feky, S. , Ibrahim, F. , Haroun, M. , Ahmmad, M. , Elnaggar, M. , Elghandour, S. and Moneim, N. (2019) Genetic Variation of hTERT, Leukocyte Telomere Length and the Risk of Breast Cancer: A Case-Control Study in Egyptian Females. Advances in Breast Cancer Research, 8, 61-76. doi: 10.4236/abcr.2019.82005.

[1]   Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.

[2]   Bray, F., McCarron, P. and Parkin, D.M. (2004) The Changing Global Patterns of Female Breast Cancer Incidence and Mortality. Breast Cancer Research, 6, 229-239.

[3]   Abdulkareem, I.H. (2013) Aetio-Pathogenesis of Breast Cancer. Nigerian Medical Journal, 54, 371-375.

[4]   Lu, W., Zhang, Y., Liu, D., Songyang, Z. and Wan, M. (2013) Telomeres-Structure, Function, and Regulation. Experimental Cell Research, 319, 133-141.

[5]   Meiliana, A., Dewi, N.M. and Wijaya, A. (2017) Telomere in Aging and Age-Related Diseases. The Indonesian Biomedical Journal, 9, 113-128.

[6]   Montpetit, A.J., Alhareeri, A.A., Montpetit, M., Starkweather, A.B., Elmore, L.W., Filler, K., et al. (2015) Telomere Length: A Review of Methods for Measurement. Nursing Research, 63, 289-299.

[7]   Artandi, S.E. and DePinho, R.A. (2010) Telomeres and Telomerase in Cancer. Carcinogenesis, 31, 9-18.

[8]   Oubaha, M., Miloudi, K., Dejda, A., Guber, V., Mawambo, G., Germain, M.A., et al. (2016) Senescence-Associated Secretory Phenotype Contributes to Pathological Angiogenesis in Retinopathy. Science Translational Medicine, 8, 362ra144.

[9]   Hiyama, E. and Hiyama, K. (2007) Telomere and Telomerase in Stem Cells. British Journal of Cancer, 96, 1020-1024.

[10]   Akincilar, S.C., Unal, B. and Tergaonkar, V. (2016) Reactivation of Telomerase in Cancer. Cellular and Molecular Life Sciences, 73, 1659-1670.

[11]   Horn, S., Figl, A., Rachakonda, P.S., Fischer, C., Sucker, A., Gast, A., et al. (2013) TERT Promoter Mutations in Familial and Sporadic Melanoma. Science, 339, 959-961.

[12]   Li, C., Yin, Z., Wu, W., Li, X. and Zhou, B. (2013) Genetic Variants in TERT-CLPTM1L Genetic Region Associated with Several Types of Cancer: A Meta-Analysis. Gene, 526, 390-399.

[13]   Long, J., Zhang, B., Signorello, L.B., Cai, Q., Deming-Halverson, S., Shrubsole, M.J., et al. (2013) Evaluating Genome-Wide Association Study-Identified Breast Cancer Risk Variants in African-American Women. PLoS ONE, 8, e58350.

[14]   Pellatt, A.J., Wolff, R.K., Torres-Mejia, G., John, E.M., Herrick, J.S., Lundgreen, A., et al. (2013) Telomere Length, Telomere-Related Genes, and Breast Cancer Risk: The Breast Cancer Health Disparities Study. Genes, Chromosomes and Cancer, 52, 595-609.

[15]   Purrington, K.S., Slager, S., Eccles, D., Yannoukakos, D., Fasching, P.A., Miron, P., et al. (2014) Genome-Wide Association Study Identifies 25 Known Breast Cancer Susceptibility Loci as Risk Factors for Triple-Negative Breast Cancer. Carcinogenesis, 35, 1012-1019.

[16]   Hofer, P., Baierl, A., Bernhart, K., Leeb, G., Mach, K., Micksche, M., et al. (2012) Association of Genetic Variants of Human Telomerase with Colorectal Polyps and Colorectal Cancer Risk. Molecular Carcinogenesis, 51, E176-E182.

[17]   Jin, G., Yoo, S.S., Cho, S., Jeon, H.S., Lee, W.K., Kang, H.G., et al. (2011) Dual Roles of a Variable Number of Tandem Repeat Polymorphism in the TERT Gene in Lung Cancer. Cancer Science, 102, 144-149.

[18]   Wang, L., Soria, J.C., Chang, Y.S., Lee, H.Y., Wei, Q. and Mao, L. (2003) Association of a Functional Tandem Repeats in the Downstream of Human Telomerase Gene and Lung Cancer. Oncogene, 22, 7123-7129.

[19]   Gil, M.E. and Coetzer, T.L. (2004) Real-Time Quantitative PCR of Telomere Length. Molecular Biotechnology, 27, 169-172.

[20]   López de Abechuco, E., Soto, M., Pardo, M.A., Haussmann, M. and Díez, G. (2013) Suitability of Real-Time Quantitative PCR to Estimate the Relative Telomere Length in European Hake (Merluccius merluccius Linnaeus, 1758). Revista de Investigación Marina, 20, 29-36.

[21]   Leem, S.H., Londono-Vallejo, J.A., Kim, J.H., Bui, H., Tubacher, E., Solomon, G., et al. (2002) The Human Telomerase Gene: Complete Genomic Sequence and Analysis of Tandem Repeat Polymorphisms in Intronic Regions. Oncogene, 21, 769-777.

[22]   Li, T., Xian, Y., Tian, T., Zhuang, X. and Chu, M. (2016) New Evidence of TERT rs2736098 Polymorphism and Cancer Risk: An Updated Meta-Analysis. Journal of B.U.ON.: Official Journal of the Balkan Union of Oncology, 21, 491-497.

[23]   Wang, J., Liu, Q., Yuan, S., Xie, W., Liu, Y., Xiang, Y., et al. (2017) Genetic Predisposition to Lung Cancer: Comprehensive Literature Integration, Meta-Analysis, and Multiple Evidence Assessment of Candidate-Gene Association Studies. Scientific Reports, 7, Article No. 8371.

[24]   Oztas, E., Kara, H., Kara, Z.P., Aydogan, M.U., Uras, C. and Ozhan, G. (2016) Association Between Human Telomerase Reverse Transcriptase Gene Variations and Risk of Developing Breast Cancer. Genetic Testing and Molecular Biomarkers, 20, 459-464.

[25]   Hashemi, M., Amininia, S., Ebrahimi, M., Hashemi, S.M., Taheri, M. and Ghavami, S. (2014) Association between hTERT Polymorphisms and the Risk of Breast Cancer in a Sample of Southeast Iranian Population. BMC Research Notes, 7, 895.

[26]   Zhou, M., Jiang, B., Xiong, M. and Zhu, X. (2018) Association between TERT rs2736098 Polymorphisms and Cancer Risk—A Meta-Analysis Publication Search and Inclusion Criteria. Frontiers in Physiology, 9, 377.

[27]   Savage, S.A., Chanock, S.J., Lissowska, J., Brinton, L.A., Richesson, D. and Peplonska, B. (2007) Genetic Variation in Five Genes Important in Telomere Biology and Risk for Breast Cancer. British Journal of Cancer, 97, 832-836.

[28]   Zheng, Y., Ogundiran, T.O., Adebamowo, C., Katherine, L., Domchek, S.M., Rebbeck, T.R., et al. (012) Lack of Association Between Common Single Nucleotide Polymorphisms in the TERT-CLPTM1L Locus and Breast Cancer in Women of African Ancestry. Breast Cancer Research and Treatment, 132, 341-345.

[29]   Pande, M., Spitz, M.R., Wu, X., Gorlov, I.P., Chen, W.V. and Amos, C.I. (2011) Novel Genetic Variants in the Chromosome 5p15.33 Region Associate with Lung Cancer Risk. Carcinogenesis, 32, 1493-1499.

[30]   Walsh, K.M., Gorlov, I.P., Hansen, H.M., Wu, X., Spitz, M.R., Zhang, H., et al. (2013) Fine-Mapping of the 5p15.33, 6p22.1-p21.31, and 15q25.1 Regions Identifies Functional and Histology-Specific Lung Cancer Susceptibility Loci in African-Americans. Cancer Epidemiology, Biomarkers & Prevention, 22, 251-260.

[31]   Sheng, X., Tong, N., Tao, G., Luo, D., Wang, M., Fang, Y., et al. (2013) TERT Polymorphisms Modify the Risk of Acute Lymphoblastic Leukemia in Chinese Children. Carcinogenesis, 34, 228-235.

[32]   Bayram, S., ülger, Y., Sümbül, A.T., Kaya, B.Y., Genc, A., Rencüzogullari, E., et al. (2016) Polymorphisms in Human Telomerase Reverse Transcriptase (hTERT) Gene and Susceptibility to Gastric Cancer in a Turkish Population: Hospital-Based Case-Control Study. Gene, 585, 84-92.

[33]   Yang, H., Li, J., Tang, R., Liu, Y., Shao, Y., Huang, Q., et al. (2015) Telomere Reverse Transcriptase (TERT) rs2735940 Increases Cancer Risk. Medical Science Monitor, 21, 612-616.

[34]   Hofer, P., Baierl, A., Feik, E., Fuhrlinger, G., Leeb, G., Mach, K., et al. (2011) MNS16A Tandem Repeats Minisatellite of Human Telomerase Gene: A Risk Factor for Colorectal Cancer. Carcinogenesis, 32, 866-871.

[35]   Iizuka, T., Sawabe, M., Takubo, K., Liu, M., Homma, Y. and Suzuki, M. (2013) hTERT Promoter Polymorphism, -1327C > T, Is Associated with the Risk of Epithelial Cancer. SpringerPlus, 2, 249.

[36]   Chen, P., Zou, P., Yan, Q., Xu, H., Zhao, P. and Gu, A. (2013) The TERT MNS16A Polymorphism Contributes to Cancer Susceptibility: Meta-Analysis of the Current Studies. Gene, 519, 266-270.

[37]   Xu, Y. (2011) Chemistry in Human Telomere Biology: Structure, Function and Targeting of Telomere DNA/RNA. Chemical Society Reviews, 40, 2719-2740.

[38]   Schoepp, N.G., Khorosheva, E.M., Schlappi, T.S., Curtis, M.S., Humphries, R.M., Angeles, L., et al. (2016) Telomere Structure and Maintenance Gene Variants and Risk of Five Cancer Types. International Journal of Cancer, 139, 2655-2670.

[39]   Mikhelson, V.M. and Spivak, I.M. (2016) Markers of Cellular Senescence. Telomere Shortening as a Marker of Cellular Senescence. Aging (Albany NY), 8, 3-11.

[40]   Liu, Y., Lei, T., Zhang, N., Zheng, Y., Kou, P., Shang, S., et al. (2018) Leukocyte Telomere Length and Risk of Gastric Cardia Adenocarcinoma. Scientific Reports, 8, 14584.

[41]   Karimi, B., Yunesian, M., Nabizadeh, R., Mehdipour, P. and Aghaie, A. (2017) Is Leukocyte Telomere Length Related with Lung Cancer Risk? A Meta-Analysis. Iranian Biomedical Journal, 21, 142-153.

[42]   Pavanello, S., Varesco, L., Gismondi, V., Bruzzi, P. and Bolognesi, C. (2018) Leucocytes Telomere Length and Breast Cancer Risk/Susceptibility: A Case-Control Study. PLoS ONE, 13, e0197522.

[43]   Cahu, J., Bustany, S. and Sola, B. (2012) Senescence-Associated Secretory Phenotype Favors the Emergence of Cancer Stem-Like Cells. Cell Death & Disease, 3, e446-e448.

[44]   Julin, B., Shui, I., Heaphy, C.M., Joshu, C.E., Meeker, A.K., Giovannucci, E., et al. (2015) Circulating Leukocyte Telomere Length and Risk of Overall and Aggressive Prostate Cancer. British Journal of Cancer, 112, 769-776.

[45]   Zöchmeister, C., Brezina, S., Hofer, P., Baierl, A., Bergmann, M.M., Bachleitner-Hofmann, T., et al. (2018) Leukocyte Telomere Length throughout the Continuum of Colorectal Carcinogenesis. Oncotarget, 9, 13582-13592.